Skip to main content
. 2020 Nov 26;13(1):100370. doi: 10.1016/j.jaim.2020.10.012

Table 2.

Characteristics of preventive studies (n = 66).

Characteristics of study Ayurveda (n = 43) Yoga & Naturopathy (n = 1) Unani (n = 4) Siddha (n = 2) Homeopathy (n = 9) Others (n = 3) Collaborative (n = 4)
Study arms
Single arm 16 0 0 0 3 1 2
Double arm 26 1 2 2 5 2 2
Multi arm 1 0 2 0 1 0 0
Sample size
≤30 3 0 0 0 1 1 0
31–100 6 1 1 0 0 0 1
101–1000 17 0 1 0 4 2 3
>1001 17 0 2 2 4 0 0
Study Population
Healthy volunteers 7 0 0 0 1 0 1
High Risk Individuals 36 1 4 2 8 3 3
Type of Intervention (where applicable)
Single drug formulation 16 0 0 0 4 1 0
Multi drug formulation 13 0 1 1 2 1 0
Multi-formulation regime 14 0 3 1 3 1 3
Non-Pharmacological 0 1 0 0 0 0 1
Use of comparators
AYUSH vs. CCa 16 0 2 2 0 1 2
AYUSH vs. Placebo/No Treatment 7 1 2 0 5 1 0
AYUSH vs. nutritional/ 2 0 0 0 1 0 0
dietary items
AYUSH + CC vs.CC or Placebo + CC 2 0 0 0 0 0 0
Treatment duration
≤7 days 1 0 0 0 3 0 0
>7 days to ≤15 days 1 0 2 1 1 2 1
>15 days to ≤30 days 17 0 1 0 0 1 0
>30 days 12 0 0 0 1 0 2
Not Specified 12 1 1 1 4 0 1
Primary Outcomes
Incidence of infection 38 1 4 2 9 3 4
Incidence of infection & AYUSH specific parameters 4 0 0 0 0 0 0
Acceptability of Intervention 1 0 0 0 0 0 0
Study Duration
≤3 months 20 1 2 0 4 0 1
>3 moths & ≤ 6 months 15 0 2 2 5 3 1
>6 months & ≤ 1 year 6 0 0 0 0 0 2
>1 year 2 0 0 0 0 0 0
a

CC: Conventional Care.